Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation

One endpoint of clinical islet cell transplantation for type 1 diabetic patients is the elimination or reduction of hypoglycemia. We previously developed a simple tool to evaluate islet graft function: the secretory unit of islet transplant objects (SUITO) index. The aim of this study is to clarify...

Full description

Bibliographic Details
Main Authors: Morihito Takita M.D., Shinichi Matsumoto M.D., Ph.D., Huanying Qin, Hirofumi Noguchi, Masayuki Shimoda, Daisuke Chujo, Takeshi Itoh, Koji Sugimoto, Nicholas Onaca, Bashoo Naziruddin, Marlon F. Levy
Format: Article
Language:English
Published: SAGE Publishing 2012-02-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368911X580617
id doaj-b686b82658224b45be69d5c000a2c909
record_format Article
spelling doaj-b686b82658224b45be69d5c000a2c9092020-11-25T03:39:32ZengSAGE PublishingCell Transplantation0963-68971555-38922012-02-012110.3727/096368911X580617Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell TransplantationMorihito Takita M.D.0Shinichi Matsumoto M.D., Ph.D.1Huanying Qin2Hirofumi Noguchi3Masayuki Shimoda4Daisuke Chujo5Takeshi Itoh6Koji Sugimoto7Nicholas Onaca8Bashoo Naziruddin9Marlon F. Levy10Islet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, TX, USAIslet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, TX, USAInstitute for Health Care Research and Improvement, Baylor Health Care System, Dallas, TX, USAIslet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, TX, USABaylor University Medical Center, Dallas, TX, USABaylor Research Institute for Immunology Research, Dallas, TX, USAIslet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, TX, USAIslet Cell Laboratory, Baylor Research Institute Fort Worth Campus, Fort Worth, TX, USABaylor Regional Transplant Institute, Dallas, TX, USABaylor Regional Transplant Institute, Dallas, TX, USABaylor Regional Transplant Institute, Dallas, TX, USAOne endpoint of clinical islet cell transplantation for type 1 diabetic patients is the elimination or reduction of hypoglycemia. We previously developed a simple tool to evaluate islet graft function: the secretory unit of islet transplant objects (SUITO) index. The aim of this study is to clarify the association between the SUITO index and hypoglycemic episodes. Data from 310 clinical evaluations of 11 islet recipients were included in this study. Fasting plasma C-peptide and glucose levels were measured at every evaluation. The SUITO index was calculated according to the following formula: 1500 × C-peptide level (ng/ml)/[blood glucose level (mg/dl) – 63]. The number of hypoglycemic events (<3.8 mmol/L) and severe hypoglycemic events (<2.2 mmol/L or hypoglycemic unawareness) was assessed on the basis of interviews and self-monitoring of blood glucose (SMBG). Receiver operating characteristic (ROC) analysis was performed to determine the cut-off values of the SUITO index for hypoglycemic events. Based on the ROC study, follow-up data after transplantations were divided into the following three groups: low-SUITO (SUITO index <10, n = 91), middle-SUITO (10 ≤SUITO index <26, n = 83), high-SUITO (SUITO index ≤26, n = 125). The frequency of total hypoglycemia in the high-SUITO group was significantly decreased when compared to the other groups (value with Kruskal-Wallis test p < 0.001). The frequency of total severe hypoglycemia was significantly decreased in the low-SUITO group compared to pretransplant status and further decreased in the middle- and high-SUITO group. Spearman correlation coefficients were −0.663 ( p < 0.001) between the number of total hypoglycemic events per one month and the SUITO index and −0.521 ( p < 0.001) between that of severe events and the SUITO index. The SUITO index could predict the severity of hypoglycemic episodes in type 1 diabetic patients who received islet cell transplantations.https://doi.org/10.3727/096368911X580617
collection DOAJ
language English
format Article
sources DOAJ
author Morihito Takita M.D.
Shinichi Matsumoto M.D., Ph.D.
Huanying Qin
Hirofumi Noguchi
Masayuki Shimoda
Daisuke Chujo
Takeshi Itoh
Koji Sugimoto
Nicholas Onaca
Bashoo Naziruddin
Marlon F. Levy
spellingShingle Morihito Takita M.D.
Shinichi Matsumoto M.D., Ph.D.
Huanying Qin
Hirofumi Noguchi
Masayuki Shimoda
Daisuke Chujo
Takeshi Itoh
Koji Sugimoto
Nicholas Onaca
Bashoo Naziruddin
Marlon F. Levy
Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
Cell Transplantation
author_facet Morihito Takita M.D.
Shinichi Matsumoto M.D., Ph.D.
Huanying Qin
Hirofumi Noguchi
Masayuki Shimoda
Daisuke Chujo
Takeshi Itoh
Koji Sugimoto
Nicholas Onaca
Bashoo Naziruddin
Marlon F. Levy
author_sort Morihito Takita M.D.
title Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
title_short Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
title_full Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
title_fullStr Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
title_full_unstemmed Secretory Unit of Islet Transplant Objects (SUITO) Index Can Predict Severity of Hypoglycemic Episodes in Clinical Islet Cell Transplantation
title_sort secretory unit of islet transplant objects (suito) index can predict severity of hypoglycemic episodes in clinical islet cell transplantation
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2012-02-01
description One endpoint of clinical islet cell transplantation for type 1 diabetic patients is the elimination or reduction of hypoglycemia. We previously developed a simple tool to evaluate islet graft function: the secretory unit of islet transplant objects (SUITO) index. The aim of this study is to clarify the association between the SUITO index and hypoglycemic episodes. Data from 310 clinical evaluations of 11 islet recipients were included in this study. Fasting plasma C-peptide and glucose levels were measured at every evaluation. The SUITO index was calculated according to the following formula: 1500 × C-peptide level (ng/ml)/[blood glucose level (mg/dl) – 63]. The number of hypoglycemic events (<3.8 mmol/L) and severe hypoglycemic events (<2.2 mmol/L or hypoglycemic unawareness) was assessed on the basis of interviews and self-monitoring of blood glucose (SMBG). Receiver operating characteristic (ROC) analysis was performed to determine the cut-off values of the SUITO index for hypoglycemic events. Based on the ROC study, follow-up data after transplantations were divided into the following three groups: low-SUITO (SUITO index <10, n = 91), middle-SUITO (10 ≤SUITO index <26, n = 83), high-SUITO (SUITO index ≤26, n = 125). The frequency of total hypoglycemia in the high-SUITO group was significantly decreased when compared to the other groups (value with Kruskal-Wallis test p < 0.001). The frequency of total severe hypoglycemia was significantly decreased in the low-SUITO group compared to pretransplant status and further decreased in the middle- and high-SUITO group. Spearman correlation coefficients were −0.663 ( p < 0.001) between the number of total hypoglycemic events per one month and the SUITO index and −0.521 ( p < 0.001) between that of severe events and the SUITO index. The SUITO index could predict the severity of hypoglycemic episodes in type 1 diabetic patients who received islet cell transplantations.
url https://doi.org/10.3727/096368911X580617
work_keys_str_mv AT morihitotakitamd secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT shinichimatsumotomdphd secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT huanyingqin secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT hirofuminoguchi secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT masayukishimoda secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT daisukechujo secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT takeshiitoh secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT kojisugimoto secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT nicholasonaca secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT bashoonaziruddin secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
AT marlonflevy secretoryunitofislettransplantobjectssuitoindexcanpredictseverityofhypoglycemicepisodesinclinicalisletcelltransplantation
_version_ 1724538179679158272